Human leukocyte antigen-associated drug hypersensitivity

Area of Science:

• Immunogenetics
• Pharmacogenomics
• Molecular immunology

Background:

• Increasing associations exist between adverse drug reactions and human leukocyte antigen (HLA) gene alleles.
• Several models explain these associations, but the molecular basis is recently elucidated.
• Specific HLA alleles are linked to severe drug reactions, such as HLA-B*57:01 with abacavir hypersensitivity and HLA-B*15:02 with carbamazepine-induced skin disease.

Purpose of the Study:

• To discuss the molecular mechanisms underlying drug hypersensitivity reactions.
• To highlight how small molecules interact with HLA molecules.
• To explore the implications for understanding other immunopathologies.

Main Methods:

• Review of recent evidence on HLA-drug interactions.
• Analysis of molecular mechanisms of drug hypersensitivity.
• Exploration of self-peptide presentation distortion.

Main Results:

• Small molecules can bind to specific HLA molecules.
• This binding distorts the presentation of self-peptides.
• This distortion leads to autoimmune-like drug hypersensitivities.

Conclusions:

• Drug hypersensitivity reactions have a molecular basis involving HLA-drug interactions.
• Altered self-peptide presentation by HLA molecules is a key mechanism.
• These findings may offer insights into the mechanisms of other immune-related diseases.